MUSK and myasthenia gravis: Studies reported that approximately 80% of MG patients demonstrate detectable autoantibodies targeting the acetylcholine receptor (AChR), while the prevalence of muscle-specific tyrosine kinase (MuSK) antibodies only ranges from 1% to 10% (2).